Expertise in
3
conditions

Francois-xavier Gros

Bordeaux, FR 
Expertise in
3
conditions
Bordeaux, FR 

Overview

Francois-xavier Gros practices practicing medicine in Bordeaux, France.

Gros is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), Anaplastic Large Cell Lymphoma, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 1 clinical trial.

Locations

Bordeaux, France
Other Locations
Merignac, France
Lyon, 69410, France
1 Avenue De Magellan, Pessac-sur-dordogne, 33600, France
Strasbourg, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase 2, Open-Label Study Evaluating Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B-Non Hodgkin Lymphoma (B-NHL) Who Are Ineligible to Autologous Stem Cell Transplantation
Phase 2, Open-Label Study Evaluating Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B-Non Hodgkin Lymphoma (B-NHL) Who Are Ineligible to Autologous Stem Cell Transplantation
Enrollment Status: Active_not_recruiting
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: Axicabtagene Ciloleucel
Study Phase: Phase 2

28 Total Publications

Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.
Journal: Journal of hematology & oncology
Published: April 01, 2026

Frequently Asked Questions about Francois-xavier Gros

Is Francois-xavier Gros a top-rated expert for B-Cell Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Francois-xavier Gros is classified as an Distinguished expert for B-Cell Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Francois-xavier Gros participate in research or clinical trials?

Yes. Francois-xavier Gros has published 28 articles and abstracts on conditions like B-Cell Lymphoma. You can view a list of Francois-xavier Gros's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gros's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile